pubmed-article:15606395 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15606395 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:15606395 | lifeskim:mentions | umls-concept:C0010346 | lld:lifeskim |
pubmed-article:15606395 | lifeskim:mentions | umls-concept:C0267561 | lld:lifeskim |
pubmed-article:15606395 | lifeskim:mentions | umls-concept:C0008809 | lld:lifeskim |
pubmed-article:15606395 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:15606395 | lifeskim:mentions | umls-concept:C0666743 | lld:lifeskim |
pubmed-article:15606395 | lifeskim:mentions | umls-concept:C0599724 | lld:lifeskim |
pubmed-article:15606395 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:15606395 | pubmed:issue | 11-12 | lld:pubmed |
pubmed-article:15606395 | pubmed:dateCreated | 2004-12-20 | lld:pubmed |
pubmed-article:15606395 | pubmed:abstractText | Ciprofloxacin is effective in perianal Crohn's disease but after treatment discontinuation symptoms reoccur. Infliximab is effective but requires maintenance therapy. | lld:pubmed |
pubmed-article:15606395 | pubmed:language | eng | lld:pubmed |
pubmed-article:15606395 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15606395 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15606395 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15606395 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15606395 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15606395 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15606395 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15606395 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15606395 | pubmed:month | Dec | lld:pubmed |
pubmed-article:15606395 | pubmed:issn | 0269-2813 | lld:pubmed |
pubmed-article:15606395 | pubmed:author | pubmed-author:WestR LRL | lld:pubmed |
pubmed-article:15606395 | pubmed:author | pubmed-author:KuipersE JEJ | lld:pubmed |
pubmed-article:15606395 | pubmed:author | pubmed-author:HanselB CBC | lld:pubmed |
pubmed-article:15606395 | pubmed:author | pubmed-author:Felt-BersmaR... | lld:pubmed |
pubmed-article:15606395 | pubmed:author | pubmed-author:van der... | lld:pubmed |
pubmed-article:15606395 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:15606395 | pubmed:author | pubmed-author:DrapersJ A... | lld:pubmed |
pubmed-article:15606395 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15606395 | pubmed:volume | 20 | lld:pubmed |
pubmed-article:15606395 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15606395 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15606395 | pubmed:pagination | 1329-36 | lld:pubmed |
pubmed-article:15606395 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:meshHeading | pubmed-meshheading:15606395... | lld:pubmed |
pubmed-article:15606395 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15606395 | pubmed:articleTitle | Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. | lld:pubmed |
pubmed-article:15606395 | pubmed:affiliation | Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands. rlwest1@hotmail.com | lld:pubmed |
pubmed-article:15606395 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15606395 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15606395 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:15606395 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15606395 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15606395 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15606395 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15606395 | lld:pubmed |